Phase2 Study of NT-702 in Patients With Adult Bronchial Asthma
Phase 2
- Conditions
- Adult Bronchial Asthma
- Registration Number
- JPRN-jRCT2080222058
- Lead Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Adult athmatics
- An outpatient
- Patients with mild to moderate asthma
etc.
Exclusion Criteria
- An inpatient
- Having critical Heart Disease, other ciruculatory disease, cerebrovascular disorder and malignancy.
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method efficacy (pulmonary function test)
- Secondary Outcome Measures
Name Time Method efficacy (clinical condition etc.)